High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: A prospective study in 59 patients

被引:41
作者
Riche, F
Panis, Y
Laisne, MJ
Briard, C
Cholley, B
BernardPoenaru, O
Graulet, AM
Gueris, J
Valleur, P
机构
[1] HOP LARIBOISIERE,DEPT SURG,F-75475 PARIS 10,FRANCE
[2] HOP LARIBOISIERE,DEPT RADIOIMMUNOL,F-75475 PARIS 10,FRANCE
关键词
D O I
10.1016/S0039-6060(96)80087-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. In several studies including patients with septic shock of various origins, high serum cytokine levels have been reported to correlate with poor outcome. The aim of this prospective study was to assess the prognostic value of cytokine serum levels in a group of patients with perioperative septic shock of digestive origin. Methods. From January 1992 to December 1994, 59 patients were evaluated (mean age, 68 +/- 15 years). From the first day of septic shock to day 7, blood was drawn every day to measure the conventional biologic parameters (white blood cell count, platelet count, hematocrit, blood urea nitrogen level serum electrolytes level, pH, blood gases, serum lactate level, coagulation parameters, liver function tests) and tumor necrosis factor (TNF), interleukin-1, and interleukin-6. Results. No difference was observed between the 26 survivors and the 33 nonsurvivors with regard to age, gender, and cause of sepsis. On admission, mean platelet count was significantly higher in the survivors than in the nonsurvivors (260 +/- 142 versus 177 +/- 122 10(9)/L; P = 0.01). Mean blood urea nitrogen level was significantly lower in the survivors than in the nonsurvivors (96 +/- 9 versus 12 +/- 7 mmol/L; p = 0.04). No difference was observed between survivors and nonsurvivors for the other conventional biologic parameters and for serum interleukin-1 and interleukin-6 levels. Mean serum TNF level tended to be higher in survivors than in nonsurvivors (565 +/- 1325 versus 94 +/- 69 pg/ml; not significant). In the group survivor 9 (35%) of 26 patients had a serum TNF level greater than 200 pg/ml versus 2 (6%) of 33 patients in the nonsurvivor group (p < 0.02). Survival was noted in 6 (100%) of 6 patients who had both a serum TNF level greater than 200 pg/ml and a platelet count greater than 100.10(9)/L versus 1 (11%) of 9 in patients with neither of these criteria (p<0.01). Conclusions. In our patients with abdominal septic shock, high serum TNF levels were associated with increased survival The high serum level of TNF may reflect the efficacy of peritoneal inflammatory response against abdominal sepsis. Although this possibility must be further explored, a score combining the serum TNF level and platelet count could be helpful for the prognostic assessment of patients with abdominal septic shock.
引用
收藏
页码:801 / 807
页数:7
相关论文
共 31 条
[11]   PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS [J].
DEBETS, JMH ;
KAMPMEIJER, R ;
VANDERLINDEN, MPMH ;
BUURMAN, WA ;
VANDERLINDEN, CJ .
CRITICAL CARE MEDICINE, 1989, 17 (06) :489-494
[12]   PLASMA TUMOR NECROSIS FACTOR LEVELS IN PATIENTS WITH PRESUMED SEPSIS - RESULTS IN THOSE TREATED WITH ANTILIPID-A ANTIBODY VS PLACEBO [J].
DEGROOTE, MA ;
MARTIN, MA ;
DENSEN, P ;
PFALLER, MA ;
WENZEL, RP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (02) :249-251
[13]  
ECHTENACHER B, 1990, J IMMUNOL, V145, P3762
[14]  
EKSTROM BF, 1986, ACTA CHIR SCAND, V152, P181
[15]   EVIDENCE FOR DIFFERENT EFFECTS OF SOLUBLE TNF-RECEPTORS ON VARIOUS TNF MEASUREMENTS IN HUMAN BIOLOGICAL-FLUIDS [J].
ENGELBERTS, I ;
STEPHENS, S ;
FRANCOT, GJM ;
VANDERLINDEN, CJ ;
BUURMAN, WA .
LANCET, 1991, 338 (8765) :515-516
[16]   MONOCLONAL-ANTIBODY TO TNF IN SEVERE SEPTIC SHOCK [J].
EXLEY, AR ;
COHEN, J ;
BUURMAN, W ;
OWEN, R ;
LUMLEY, J ;
BODMER, M ;
STEPHENS, S ;
HANSON, G ;
AULAKH, JM ;
RIDDELL, A ;
PERRY, M .
LANCET, 1990, 335 (8700) :1275-1277
[17]   INFLUENCE OF AN ANTITUMOR NECROSIS FACTOR MONOCLONAL-ANTIBODY ON CYTOKINE LEVELS IN PATIENTS WITH SEPSIS [J].
FISHER, CJ ;
OPAL, SM ;
DHAINAUT, JF ;
STEPHENS, S ;
ZIMMERMAN, JL ;
NIGHTINGALE, P ;
HARRIS, SJ ;
SCHEIN, RMH ;
PANACEK, EA ;
VINCENT, JL ;
FOULKE, GE ;
WARREN, EL ;
GARRARD, C ;
PARK, G ;
BODMER, MW ;
COHEN, J ;
VANDERLINDEN, C ;
CROSS, AS ;
SADOFF, JC ;
GORECKI, J ;
DUBIN, HG ;
GARNER, C ;
KAYE, W ;
LANORE, JJ ;
MIRA, JP ;
ZIMMERMAN, J ;
DELLINGER, RP ;
TAYLOR, RW ;
DAHL, S ;
SHELLY, M ;
MORTIMER, A ;
EDWARDS, JD ;
KETT, DH ;
QUARTIN, A ;
PENA, MA ;
BAKKER, J ;
ALBERSON, TE ;
WALBY, W ;
RADCLIFFE, J ;
YOUNG, D ;
MCQUILLAM, P ;
BELLINGHAM, G ;
BURMAN, W ;
SADOFF, JS ;
YOUNG, L .
CRITICAL CARE MEDICINE, 1993, 21 (03) :318-327
[18]  
FUGGER R, 1993, EUR J SURG, V159, P525
[19]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 IN THE SERUM OF CHILDREN WITH SEVERE INFECTIOUS PURPURA [J].
GIRARDIN, E ;
GRAU, GE ;
DAYER, JM ;
ROUXLOMBARD, P ;
LAMBERT, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (07) :397-400
[20]  
GISLI H, 1992, CRIT CARE MED, V20, P458